Download PDF
J Pediatr Genet 2023; 12(02): 129-134
DOI: 10.1055/s-0041-1733950
Original Article

The HBG2 rs7482144 (C > T) Polymorphism is Linked to HbF Levels but not to the Severity of Sickle Cell Anemia

Bhaskar V. K. S. Lakkakula 
1   Department of Zoology, Guru Ghasidas Vishwavidyalaya, Bilaspur, Chhattisgarh, India
,
Smaranika Pattnaik
2   Department of Biotechnology and Bioinformatics, Sambalpur University, Sambalpur, Odisha, India
› Author Affiliations Funding This work was supported by Chhattisgarh Council of Science & Technology (CCOST) project (No.2740/CCOST/MRP/2015).
› Further Information
    Permissions and Reprints

Abstract

Sickle cell anemia (SCA) is a severe disease characterized by anemia, acute clinical complications, and a relatively short life span. In this disease, abnormal hemoglobin makes the red blood cells deformed, rigid, and sticky. Fetal hemoglobin (HbF) is one of the key modulators of SCA morbidity and mortality. Interindividual HbF variation is a heritable trait that is controlled by polymorphism in genes linked and unlinked to the hemoglobin β gene (HBB). The genetic polymorphisms that determine HbF levels are known to ameliorate acute clinical events. About 190 well-characterized homozygous SCA patients were included in this study. Complete blood count (CBC), high-performance liquid chromatography (HPLC), and clinical investigations were obtained from patient's records. Severity scores were determined by using the combination of anemia, complications, total leucocyte count, and transfusion scores. HBG2 rs7482144 polymorphism was genotyped by using the polymerase chain reaction and restriction fragment length polymorphism. The association between HBG2 rs7482144 polymorphism and HbF levels as well as the disease severity of SCA were assessed. SCA patients carrying TT genotype were found to have higher HbF levels. In addition, SCA patients with increased severity showed significantly lower levels of hemoglobin, HbF, and hematocrit values. However, the genotypes of HBG2 rs7482144 polymorphism were not found to be associated with the risk of disease severity. In summary, this study demonstrated that HBG2 rs7482144 polymorphism is linked with HbF levels, but it does not affect disease severity. The sample sizes used and the pattern of association deduced from our small sample size prevents us from extrapolating our findings further.

Keywords

sickle cell anemia - HBG2 rs7482144 polymorphism - fetal hemoglobin - severity scores


Publication History

Received: 27 April 2021

Accepted: 08 July 2021

Article published online:
31 August 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Piel FB, Steinberg MH, Rees DC. Sickle cell disease. N Engl J Med 2017; 376 (16) 1561-1573
    CrossrefPubMedGoogle Scholar
  • 2 Bhanushali AA, Patra PK, Nair D, Verma H, Das BR. Genetic variant in the BCL11A (rs1427407), but not HBS1-MYB (rs6934903) loci associate with fetal hemoglobin levels in Indian sickle cell disease patients. Blood Cells Mol Dis 2015; 54 (01) 4-8
    CrossrefPubMedGoogle Scholar
  • 3 Lakkakula BVKS, Sahoo R, Verma H, Lakkakula S. Pain management issues as part of the comprehensive care of patients with sickle cell disease. Pain Manag Nurs 2018; 19 (06) 558-572
    CrossrefPubMedGoogle Scholar
  • 4 Darshana T, Bandara D, Nawarathne U. et al. Sickle cell disease in Sri Lanka: clinical and molecular basis and the unanswered questions about disease severity. Orphanet J Rare Dis 2020; 15 (01) 177
    CrossrefPubMedGoogle Scholar
  • 5 Lakkakula BVKS. Association between MTHFR 677C>T polymorphism and vascular complications in sickle cell disease: a meta-analysis. Transfus Clin Biol 2019; 26 (04) 284-288
    CrossrefPubMedGoogle Scholar
  • 6 Bhaskar LV, Factor V. Leiden and prothrombin G20210A mutations and risk of vaso-occlusive complications in sickle cell disease: a meta-analysis through the lens of nephrology. J Nephropharmacol 2019; 8: e16
    CrossrefPubMedGoogle Scholar
  • 7 Verma H, Mishra H, Khodiar PK, Patra PK, Bhaskar LV. NOS3 27-bp and IL4 70-bp VNTR polymorphisms do not contribute to the risk of sickle cell crisis. Turk J Haematol 2016; 33 (04) 365-366
    CrossrefPubMedGoogle Scholar
  • 8 Olaniyi JA, Arinola OG, Odetunde AB. Foetal haemoglobin (HbF) status in adult sickle cell anaemia patients in Ibadan, Nigeria. Ann Ib Postgrad Med 2010; 8 (01) 30-33
    PubMedGoogle Scholar
  • 9 Thein SL, Menzel S. Discovering the genetics underlying foetal haemoglobin production in adults. Br J Haematol 2009; 145 (04) 455-467
    CrossrefPubMedGoogle Scholar
  • 10 Estepp JH, Smeltzer MP, Kang G. et al. A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy. Am J Hematol 2017; 92 (12) 1333-1339
    CrossrefPubMedGoogle Scholar
  • 11 Henu Kumar V, Saikrishna L, Bhaskar VKSL. Retrospection of the effect of hydroxyurea treatment in patients with sickle cell disease. Acta Haematol Pol 2018; 49: 1-8
    CrossrefPubMedGoogle Scholar
  • 12 Pule GD, Mowla S, Novitzky N, Wiysonge CS, Wonkam A. A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease. Expert Rev Hematol 2015; 8 (05) 669-679
    CrossrefPubMedGoogle Scholar
  • 13 Shen Y, Bassett MA, Gurumurthy A. et al. Identification of a novel enhancer/chromatin opening element associated with high-level γ-globin gene expression. Mol Cell Biol 2018; 38 (19) e00197-e18
    CrossrefPubMedGoogle Scholar
  • 14 Bhaskar L. Genetic screening in sickle cell anemia. Polymorphism 2019; 3: 35-37
    PubMedGoogle Scholar
  • 15 Pandey S, Pandey S, Mishra RM, Saxena R. Modulating effect of the -158 γ (C→T) Xmn1 polymorphism in indian sickle cell patients. Mediterr J Hematol Infect Dis 2012; 4 (01) e2012001
    CrossrefPubMedGoogle Scholar
  • 16 Cardoso GL, Diniz IG, Silva AN. et al. DNA polymorphisms at BCL11A, HBS1L-MYB and Xmn1-HBG2 site loci associated with fetal hemoglobin levels in sickle cell anemia patients from Northern Brazil. Blood Cells Mol Dis 2014; 53 (04) 176-179
    CrossrefPubMedGoogle Scholar
  • 17 Gilman JG, Huisman TH. Two independent genetic factors in the beta-globin gene cluster are associated with high G gamma-levels in the HbF of SS patients. Blood 1984; 64 (02) 452-457
    CrossrefPubMedGoogle Scholar
  • 18 Patra PK, Khodiar PK, Hambleton IR, Serjeant GR. The Chhattisgarh state screening programme for the sickle cell gene: a cost-effective approach to a public health problem. J Community Genet 2015; 6 (04) 361-368
    CrossrefPubMedGoogle Scholar
  • 19 van den Tweel XW, van der Lee JH, Heijboer H, Peters M, Fijnvandraat K. Development and validation of a pediatric severity index for sickle cell patients. Am J Hematol 2010; 85 (10) 746-751
    CrossrefPubMedGoogle Scholar
  • 20 Sambrook J, Russell DW. Molecular cloning: a laboratory manual. 3rd edition. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press; 2001
    Google Scholar
  • 21 Bhaskar LVKS, Patra PK. Sickle cell disease is autochthonous and unique in Indian populations. Indian J Phys Anthropol Hum Genet 2015; 34: 201-210
    PubMedGoogle Scholar
  • 22 Rumaney MB, Ngo Bitoungui VJ, Vorster AA. et al. The co-inheritance of alpha-thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival. PLoS One 2014; 9 (06) e100516
    CrossrefPubMedGoogle Scholar
  • 23 Fertrin KY, Costa FF. Genomic polymorphisms in sickle cell disease: implications for clinical diversity and treatment. Expert Rev Hematol 2010; 3 (04) 443-458
    CrossrefPubMedGoogle Scholar
  • 24 Maier-Redelsperger M, Noguchi CT, de Montalembert M. et al. Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life: Parisian Prospective Study on Sickle Cell Disease. Blood 1994; 84 (09) 3182-3188
    CrossrefPubMedGoogle Scholar
  • 25 Akinsheye I, Alsultan A, Solovieff N. et al. Fetal hemoglobin in sickle cell anemia. Blood 2011; 118 (01) 19-27
    CrossrefPubMedGoogle Scholar
  • 26 Nagel RL, Fabry ME, Pagnier J. et al. Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type. N Engl J Med 1985; 312 (14) 880-884
    CrossrefPubMedGoogle Scholar
  • 27 Habara AH, Shaikho EM, Steinberg MH. Fetal hemoglobin in sickle cell anemia: the Arab-Indian haplotype and new therapeutic agents. Am J Hematol 2017; 92 (11) 1233-1242
    CrossrefPubMedGoogle Scholar
  • 28 Sheehan VA, Luo Z, Flanagan JM. et al; BABY HUG Investigators. Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes. Am J Hematol 2013; 88 (07) 571-576
    CrossrefPubMedGoogle Scholar
  • 29 Das S. A study to understand the relation between fetal haemoglobin, the hematological parameters and Xmn i gene polymorphism. Indian Journal of Medicine and Healthcare 2012; 1: 206-210
    PubMedGoogle Scholar
  • 30 Alaoui-Ismaili F-Z, Laghmich A, Ghailani-Nourouti N, Barakat A, Bennani-Mechita M, Xmn I. XmnI polymorphism in sickle cell disease in North Morocco. Hemoglobin 2020; 44 (03) 190-194
    CrossrefPubMedGoogle Scholar
  • 31 Mohamed GS, Lemine SM, A-S Kleib, Najjar F, Mohamed A. Modulator effect of XmnI polymorphism concerning 50 Mauritanian sickle cell disease patients. Int J Sci Res 2018; 7: 1384-1387
    PubMedGoogle Scholar
  • 32 Garner C, Tatu T, Game L. et al. A candidate gene study of F cell levels in sibling pairs using a joint linkage and association analysis. GeneScreen 2000; 1: 9-14
    CrossrefPubMedGoogle Scholar
  • 33 Lettre G, Sankaran VG, Bezerra MA. et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci USA 2008; 105 (33) 11869-11874
    CrossrefPubMedGoogle Scholar